Literature DB >> 21541758

Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation?

Joachim R Ehrlich, Dobromir Dobrev.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541758     DOI: 10.1007/s00210-011-0647-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  33 in total

1.  Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.

Authors:  Alexander Burashnikov; Luiz Belardinelli; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2010-05-15       Impact factor: 6.343

Review 2.  Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.

Authors:  Joachim R Ehrlich; Stanley Nattel; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2002-04

3.  Atrial L-type Ca2+ currents and human atrial fibrillation.

Authors:  D R Van Wagoner; A L Pond; M Lamorgese; S S Rossie; P M McCarthy; J M Nerbonne
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367

4.  Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.

Authors:  Nathalie Gaborit; Marja Steenman; Guillaume Lamirault; Nolwenn Le Meur; Sabrina Le Bouter; Gilles Lande; Jean Léger; Flavien Charpentier; Torsten Christ; Dobromir Dobrev; Denis Escande; Stanley Nattel; Sophie Demolombe
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

5.  The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.

Authors:  Jakob Gierten; Eckhard Ficker; Ramona Bloehs; Patrick A Schweizer; Edgar Zitron; Eberhard Scholz; Christoph Karle; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-24       Impact factor: 3.000

6.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study.

Authors:  Paul Touboul; Josep Brugada; Alessandro Capucci; Harry J G M Crijns; Nils Edvardsson; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2003-08       Impact factor: 29.983

7.  Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.

Authors:  Niels Voigt; Nadiia Rozmaritsa; Anne Trausch; Thomasz Zimniak; Torsten Christ; Erich Wettwer; Klaus Matschke; Dobromir Dobrev; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-17       Impact factor: 3.000

8.  Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.

Authors:  M J Suttorp; J H Kingma; L Lie-A-Huen; E G Mast
Journal:  Am J Cardiol       Date:  1989-03-15       Impact factor: 2.778

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

Review 10.  Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation.

Authors:  José Jalife; Omer Berenfeld; Moussa Mansour
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  3 in total

1.  Pleiotropic actions of amiodarone: still puzzling after half a century.

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-09       Impact factor: 3.000

2.  Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation.

Authors:  Jordi Heijman; Gerd Heusch; Dobromir Dobrev
Journal:  Clin Med Insights Cardiol       Date:  2013-08-11

3.  Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation.

Authors:  Nakkawee Saengklub; Vudhiporn Limprasutr; Suwanakiet Sawangkoon; Robert L Hamlin; Anusak Kijtawornrat
Journal:  Exp Anim       Date:  2017-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.